Recolony is among the Top 3 biotech startups that are leading the Top100 public voting 2024
Newsroom
Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.
Talking about Recolony for X-Health.show podcast
FOUNDED Spotlights Recolony's Innovative Approach to Cancer Therapy
Our CEO, Ana Montalban-Arques is featured in the Swisspreneur podcast
Our COO, Philipp Busenhart, will present Recolony at the Biotech Showcase in San Francisco
Our CEO, Ana Montalban-Arques, will be presenting Recolony next January at the Microbiome Movement Drug Development.
Recolony is selected as one of the Startup Spotlight finalists at BIO-EUROPE 2023
Recolony is among the15 most promising Swiss biotech startups of 2023, according to investors
Recolony among the Top100 Swiss Startups
Recolony gets featured by Handelzeitung
Recolony receives CHF 150,000 from Venture Kick
Recolony nominated as "Newcomer of the year"
Recolony selected as one of the Hello Tomorrow Deep Tech Pioneers!
Recolony gets support from InnoBooster
SWICA interviews Recolony
Recolony is selected for Venture Leaders Biotech
Recolony wins Venture Kick Stage II
Recolony gets the Kick!
Our CEO is highlighted in the UZH Annual Report 2021
We are finalists of >>venture>>, Switzerlands leading startup competition
We are part of the Swiss Microbiomes Forum